Publication Name	World Journal of Clinical Cases
Manuscript ID	91186
Country	China

Received	2023-12-24 03:40
Peer-Review Started	2023-12-24 03:40
To Make the First Decision
Return for Revision	2024-03-05 20:25
Revised	2024-03-06 15:13
Second Decision	2024-04-16 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-16 08:17
Articles in Press	2024-04-16 08:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-27 15:43
Publish the Manuscript Online	2024-05-29 12:34

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Minireviews
Article Title	Advanced nanomedicines and immunotherapeutics to treat respiratory diseases especially COVID-19 induced thrombosis
Manuscript Source	Unsolicited Manuscript
All Author List	Jie Wu, Ying Zheng, Li-Na Zhang, Cai-Li Gu, Wang-Li Chen and Min-Qiang Chang
ORCID	Author(s) ORCID Number Jie Wu http://orcid.org/0009-0008-5182-2924 Min-Qiang Chang http://orcid.org/0009-0007-4345-1724
Funding Agency and Grant Number
Corresponding Author	Min-Qiang Chang, MD, PhD, Chief Physician, Department of Otorhinolaryngology, 72nd Group Army Hospital of PLA, Chezhan Road, Wuxing District, Huzhou 313000, Zhejiang Province, China. cmqent98@163.com
Key Words	Nanomedicines; Immunotherapeutics; Respiratory diseases; COVID-19; Thrombosis
Core Tip	Respiratory infectious diseases have been known for their leading role in causing of morbidity and mortality, and thus are serious threat to global healthcare systems. Coronavirus disease 2019 (COVID-19) and H1N1 influenza viral diseases, and tuberculosis are respiratory infection disease that have caused huge burden on healthcare system and caused death in millions of people across the globe. Immune system plays critical role to control these infections such that COVID-19 triggers immune responses and activates inflammatory reactions soon after the viral entrance into the body. Meanwhile antiinflammatory responses are generated to decrease the severity of symptoms and proceed for recovery. In this regard researchers have reported unique involvement of NETosis in the case of COVID-19 pathophysiology that contributes prominently to the progression and development of disease. Therefore, targeting specific points using immunotherpeutic molecules, serious infections can be controlled or eradicated.
Publish Date	2024-05-29 12:34
Citation	<p>Wu J, Zheng Y, Zhang LN, Gu CL, Chen WL, Chang MQ. Advanced nanomedicines and immunotherapeutics to treat respiratory diseases especially COVID-19 induced thrombosis. <i>World J Clin Cases</i> 2024; 12(16): 2704-2712</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i16/2704.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i16.2704

Full Article (PDF)	WJCC-12-2704-with-cover.pdf
Manuscript File	91186_Auto_Edited-LJH-YJP.docx
Answering Reviewers	91186-Answering reviewers.pdf
Audio Core Tip	91186-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	91186-Conflict-of-interest statement.pdf
Copyright License Agreement	91186-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	91186-Language certificate.pdf
Peer-review Report	91186-Peer-review(s).pdf
Scientific Misconduct Check	91186-Bing-Liu JH-2.png
Scientific Misconduct Check	91186-CrossCheck.png
Scientific Editor Work List	91186-Scientific editor work list.pdf
CrossCheck Report	91186-CrossCheck report.pdf